Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 12

Results: 12

Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1261, doi. 10.1007/s00262-014-1604-1

By:

Liu, Wen-Juan;
Liu, Xiu-Jun;
Li, Liang;
Li, Yi;
Zhang, Sheng-Hua;
Zhen, Yong-Su

Publication type:

Article

A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1251, doi. 10.1007/s00262-014-1595-y

By:

Reuschenbach, Miriam;
Dörre, Jonathan;
Waterboer, Tim;
Kopitz, Jürgen;
Schneider, Martin;
Hoogerbrugge, Nicoline;
Jäger, Elke;
Kloor, Matthias;
Knebel Doeberitz, Magnus

Publication type:

Article

Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1273, doi. 10.1007/s00262-014-1596-x

By:

Kuehnle, Marie-Cristine;
Attig, Sebastian;
Britten, Cedrik;
Schulze-Bergkamen, Henning;
Lordick, Florian;
Wichert, Goetz;
Thuss-Patience, Peter;
Stein, Alexander;
Schuler, Martin;
Bassermann, Florian;
Sahin, Ugur;
Türeci, Özlem

Publication type:

Article

Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1285, doi. 10.1007/s00262-014-1597-9

By:

Wu, Licun;
Yun, Zhihong;
Tagawa, Tetsuzo;
Maza, Luis;
Wu, Matthew;
Yu, Julie;
Zhao, Yidan;
Perrot, Marc

Publication type:

Article

Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1307, doi. 10.1007/s00262-014-1603-2

By:

Tucker, Jo;
Jochems, Caroline;
Boyerinas, Benjamin;
Fallon, Jonathan;
Greiner, John;
Palena, Claudia;
Rodell, Timothy;
Schlom, Jeffrey;
Tsang, Kwong-Yok

Publication type:

Article

High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1319, doi. 10.1007/s00262-014-1594-z

By:

Ghods, Roya;
Ghahremani, Mohammad-Hossein;
Madjd, Zahra;
Asgari, Mojgan;
Abolhasani, Maryam;
Tavasoli, Sanaz;
Mahmoudi, Ahmad-Reza;
Darzi, Maryam;
Pasalar, Parvin;
Jeddi-Tehrani, Mahmood;
Zarnani, Amir-Hassan

Publication type:

Article

Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1329, doi. 10.1007/s00262-014-1605-0

By:

Foureau, David;
Amin, Asim;
White, Richard;
Anderson, William;
Jones, Chase;
Sarantou, Terry;
McKillop, Iain;
Salo, Jonathan

Publication type:

Article

Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1297, doi. 10.1007/s00262-014-1606-z

By:

Hattar, Katja;
Franz, Katharina;
Ludwig, Michael;
Sibelius, Ulf;
Wilhelm, Jochen;
Lohmeyer, Jürgen;
Savai, Rajkumar;
Subtil, Florentine;
Dahlem, Gabriele;
Eul, Bastian;
Seeger, Werner;
Grimminger, Friedrich;
Grandel, Ulrich

Publication type:

Article

Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1341, doi. 10.1007/s00262-014-1607-y

By:

Pedersen, Magnus;
Andersen, Rikke;
Nørgaard, Peter;
Jacobsen, Søren;
Thielsen, Peter;
thor Straten, Per;
Svane, Inge

Publication type:

Article

Retraction Note to: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

Published in:

2014

By:

Yamamoto, Nobuto;
Suyama, Hirofumi;
Nakazato, Hiroaki;
Yamamoto, Nobuyuki;
Koga, Yoshihiko

Publication type:

Erratum

Bioinformatics for cancer immunotherapy target discovery.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1235, doi. 10.1007/s00262-014-1627-7

By:

Olsen, Lars;
Campos, Benito;
Barnkob, Mike;
Winther, Ole;
Brusic, Vladimir;
Andersen, Mads

Publication type:

Article

Inconsistencies and questionable reliability of the publication 'Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF' by Yamamoto et al.

Published in:

2014

By:

Ugarte, Ana;
Bouche, Gauthier;
Meheus, Lydie

Publication type:

Letter